|
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') |
151.18 |
|
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] |
72.96 |
|
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs |
72.85 |
|
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML |
57.24 |
|
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis |
40.93 |
|
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium |
32.97 |
|
Role of CD133 molecule in WNT response and renal repair |
32.64 |
|
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma |
32.35 |
|
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] |
31.68 |
|
TGF-β promotes genomic instability after loss of RUNX3 |
30.28 |
|
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity |
29.33 |
|
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development |
28.46 |
|
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice |
27.35 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes |
26.9 |
|
Tumor exosome integrins determine organotropic metastasis |
25.76 |
|
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes |
25.29 |
|
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] |
24.81 |
|
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing |
24.81 |
|
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data |
24.38 |
|
Transcriptome analysis of SKI knock-out in HL60 cells |
23.72 |
|
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 |
23.72 |
|
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer |
23.64 |
|
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions |
23.49 |
|
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures |
22.31 |
|
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons |
22.14 |
|
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing |
21.66 |
|
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells |
21.37 |
|
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq |
21.23 |
|
Gene expression changes upon drug withdrawal (Mel888 cell line) |
21.16 |
|
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells |
21.08 |
|
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects |
20.66 |
|
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates |
20.65 |
|
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers |
19.65 |
|
Transcriptome analysis of U87 cells upon LINC00152 knockdown |
19.51 |
|
Total RNA-seq in ALL-SIL upon JQ1 inhibition |
19.37 |
|
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation |
19.32 |
|
RNA-sequencing of formalin fixed human primary melanoma tissue |
19.25 |
|
MYCi975 regulates MYC target genes |
19.23 |
|
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis |
18.74 |
|
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] |
18.74 |
|
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease |
18.65 |
|
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration |
18.51 |
|
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma |
18.21 |
|
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] |
18.2 |
|
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx |
18.13 |
|
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx |
18.13 |
|
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth |
18.12 |
|
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines |
17.97 |
|
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) |
17.96 |
|
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation |
17.79 |
|
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] |
17.61 |
|
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells |
17.6 |
|
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients |
17.59 |
|
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation |
17.45 |
|
Human neutrophil genome during PMA- and E. coli encounter-induced activation |
17.45 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
17.42 |
|
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing |
16.94 |
|
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] |
16.89 |
|
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer |
16.89 |
|
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. |
16.89 |
|
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells |
16.69 |
|
Regulation of highly expressed hCINAP on translatome |
16.45 |
|
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation |
16.22 |
|
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation |
16.22 |
|
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) |
16.21 |
|
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells |
16.19 |
|
A map of gene expression in neutrophil-like cell lines |
16.17 |
|
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks |
16.02 |
|
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells |
15.94 |
|
Differentially expressed genes post knock down of lincDUSP26 |
15.81 |
|
ZIKV infection of monocytes activates inflammasome pathways |
15.59 |
|
Genome wide expression change in LCC2 and MCF-7 cells |
15.33 |
|
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer |
15.25 |
|
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) |
15.25 |
|
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells |
15.14 |
|
RNA expression following TMPRSS11B overexpression or depletion |
15.11 |
|
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] |
15.1 |
|
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia |
15.01 |
|
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) |
15.01 |
|
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells |
14.87 |
|
TFAP2C signalling in human fibroblasts |
14.84 |
|
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells |
14.62 |
|
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells |
14.52 |
|
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism |
14.45 |
|
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells |
14.43 |
|
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases |
14.38 |
|
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation |
14.36 |
|
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations |
14.2 |
|
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
14.04 |
|
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines |
14.03 |
|
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] |
14.03 |
|
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma |
13.84 |
|
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] |
13.84 |
|
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ |
13.82 |
|
Identifying the molecular mode of action of itraconazole in colorectal cancer |
13.77 |
|
The comparison of high-throughput single-cell RNA-seq methods |
13.74 |
|
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays |
13.73 |
|
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates |
13.58 |
|
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell |
13.57 |
|
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing |
13.56 |
|
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells |
13.54 |
|
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] |
13.52 |
|
RNA m5C Methylation in breast cancer using MeRIP-Seq |
13.49 |
|
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase |
13.47 |
|
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization |
13.35 |
|
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity |
13.35 |
|
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] |
13.3 |
|
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition |
13.3 |
|
WRN knockout effects upon gene expression in SW48 and OVK18 |
13.26 |
|
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors |
13.01 |
|
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes |
13.01 |
|
Effect of disulfiram treatment on pediatric high grade glioma |
12.99 |
|
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site |
12.97 |
|
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] |
12.94 |
|
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer |
12.94 |
|
RNA sequencing of primary human platelets and in vitro cell lines |
12.94 |
|
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells |
12.93 |
|
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells |
12.91 |
|
Ectoderm specification of H1 human embryonic stem cells |
12.89 |
|
|
12.87 |
|
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat |
12.78 |
|
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA |
12.74 |
|
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins |
12.71 |
|
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines |
12.68 |
|
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism |
12.66 |
|
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell |
12.64 |
|
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells |
12.59 |
|
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation |
12.56 |
|
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma |
12.47 |
|
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions |
12.33 |
|
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) |
12.33 |
|
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells |
12.32 |
|
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] |
12.31 |
|
Effect of MDK expressing Melanoma cells conditioned media in Human LEC |
12.28 |
|
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells |
12.25 |
|
Accurate annotation of human protein-coding small open reading frames |
12.21 |
|
Expression levels of genes of NKG2C+ NK cells after in vitro treatment |
12.15 |
|
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth |
12.15 |
|
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 |
12.13 |
|
TGF-β regulation of miRNA expression in pancreatic cancer |
12.13 |
|
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells |
11.92 |
|
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα |
11.92 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes |
11.9 |
|
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) |
11.9 |
|
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] |
11.9 |
|
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer |
11.9 |
|
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA |
11.86 |
|
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential |
11.84 |
|
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 |
11.81 |
|
Gene expression profiling of KSHV-infected periodontal ligament cells |
11.8 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA |
11.8 |
|
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients |
11.74 |
|
NRDE2 negatively regulates nuclear exosome functions |
11.71 |
|
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] |
11.67 |
|
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia |
11.67 |
|
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity |
11.65 |
|
ARID1A and ARID1B loss in HCT116 cells |
11.65 |
|
RNA-sequencing in irradiated and normal A549 cells. |
11.63 |
|
The mechanism of HHT in treating acute myeloid leukemia on RNA level. |
11.62 |
|
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation |
11.55 |
|
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions |
11.54 |
|
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C |
11.49 |
|
RNA-seq of tumor cells following angiopellosis extravasation |
11.48 |
|
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity |
11.4 |
|
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed |
11.4 |
|
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma |
11.4 |
|
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling |
11.29 |
|
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A |
11.19 |
|
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes |
11.16 |
|
RNA-seq differential expression studies: more sequence, or more replication? |
11.14 |
|
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] |
11.07 |
|
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells |
11.07 |
|
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts |
11.05 |
|
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I |
11.03 |
|
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells |
11.01 |
|
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. |
10.99 |
|
Generation and functional characterization of MDSC-like cells |
10.95 |
|
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells |
10.92 |
|
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma |
10.89 |
|
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy |
10.88 |
|
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] |
10.78 |
|
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) |
10.78 |
|
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification |
10.73 |
|
Impact of dieldrin on transcription in Jurkat T cells |
10.68 |
|
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma |
10.65 |
|
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model |
10.6 |
|
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens |
10.55 |
|
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division |
10.55 |
|
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner |
10.51 |
|
Expression analysis of genes modulated after knock-down of lncRNA CHROME. |
10.43 |
|
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes |
10.41 |
|
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation |
10.37 |
|
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line |
10.37 |
|
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality |
10.28 |
|
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. |
10.24 |
|
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] |
10.13 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition |
10.1 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) |
10.1 |
|
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) |
10.09 |
|
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis |
10.04 |
|
RNA-seq analysis of AML cells in response to ASLAN003 |
10.03 |
|
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution |
10.02 |
|
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF |
10.01 |
|
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. |
10.0 |
|
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment |
10.0 |
|
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] |
9.96 |
|
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation |
9.96 |
|
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) |
9.95 |
|
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation |
9.93 |
|
RNA sequencing of human mammary epithelial cells |
9.9 |
|
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant |
9.89 |
|
FOXD3 is a novel tumor suppressor in lung cancer |
9.88 |
|
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
9.87 |
|
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
9.87 |
|
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. |
9.87 |
|
Gene expression changes associated with resistance to tagraxofusp (SL-401) |
9.87 |
|
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid |
9.81 |
|
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis |
9.8 |
|
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments |
9.69 |
|
Integrin signaling regulates YAP/TAZ to control skin homeostasis |
9.68 |
|
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma |
9.67 |
|
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death |
9.65 |
|
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen |
9.65 |
|
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing |
9.62 |
|
The regulartory role of ZCCHC24 in splicing machinery |
9.59 |
|
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines |
9.57 |
|
Functional studies of missense TREM2 mutations in human stem cell-derived microglia |
9.57 |
|
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown |
9.53 |
|
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production |
9.49 |
|
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection |
9.47 |
|
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] |
9.42 |
|
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia |
9.42 |
|
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 |
9.41 |
|
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation |
9.39 |
|
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] |
9.36 |
|
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha |
9.31 |
|
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer |
9.3 |
|
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway |
9.26 |
|
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA |
9.25 |
|
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. |
9.22 |
|
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment |
9.22 |
|
Uridylation by TUT4 and TUT7 marks mRNA for degradation |
9.21 |
|
Sensing self and nonself circular RNAs |
9.19 |
|
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) |
9.16 |
|
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation |
9.16 |
|
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence |
9.15 |
|
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] |
9.15 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 |
9.07 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) |
9.07 |
|
The Genomic Landscape of Atypical Fibroxanthoma |
9.06 |
|
Comprehensive comparative analysis of 5’ end RNA sequencing methods |
9.06 |
|
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) |
8.91 |
|
RNA-seq of YB5 and MCF7 treated with different doses of decitabine |
8.88 |
|
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) |
8.85 |
|
Identification of global regulators of T-helper cell lineage specification |
8.85 |
|
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique |
8.83 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) |
8.77 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia |
8.77 |
|
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] |
8.66 |
|
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells |
8.66 |
|
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated |
8.62 |
|
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia |
8.6 |
|
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) |
8.6 |
|
Regulation of Lipids is Central to Replicative Senescence |
8.57 |
|
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures |
8.54 |
|
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] |
8.54 |
|
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity |
8.48 |
|
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts |
8.48 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] |
8.37 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 |
8.37 |
|
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs |
8.32 |
|
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment |
8.27 |
|
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] |
8.23 |
|
CD73 knockdown effect in pancreatic cancer cell lines |
8.17 |
|
O-glcnAc reprograms cellular energetics |
8.15 |
|
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors |
8.11 |
|
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells |
8.09 |
|
KLF6-dependent transcription in renal cancer cells |
8.02 |
|
Expression and functions of long noncoding RNAs during human T helper cell differentiation |
7.92 |
|
High-throughput sequencing of pluripotent cells |
7.87 |
|
Fbxo32 mediated gene expression program underlies EMT and metastasis |
7.85 |
|
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer |
7.79 |
|
CDK12 mediated transcriptional regulation in U2OS cells |
7.75 |
|
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α |
7.71 |
|
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] |
7.65 |
|
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] |
7.61 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis |
7.46 |
|
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] |
7.46 |
|
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia |
7.46 |
|
Leucegene: AML sequencing (part 6) |
7.43 |
|
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] |
7.41 |
|
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells |
7.41 |
|
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells |
7.39 |
|
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML |
7.35 |
|
RNAseq of T-ALL upon long non coding rna purturbation |
7.34 |
|
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
7.32 |
|
mRNA expression profile of Lymphocytes by high-throuput sequencing |
7.31 |
|
Macrophage Ad5f35 M2 Challenge |
7.3 |
|
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing |
7.23 |
|
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors |
7.22 |
|
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells |
7.18 |
|
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition |
7.15 |
|
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] |
7.15 |
|
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq |
7.14 |
|
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma |
7.12 |
|
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells |
7.07 |
|
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts |
7.05 |
|
AMPK signaling for naïve pluripotency |
7.04 |
|
AMPK signaling for naïve pluripotency [Hs] |
7.04 |
|
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex |
6.97 |
|
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 |
6.94 |
|
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 |
6.94 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner |
6.93 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] |
6.93 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability |
6.93 |
|
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) |
6.93 |
|
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation |
6.92 |
|
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression |
6.88 |
|
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder |
6.84 |
|
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities |
6.8 |
|
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis |
6.78 |
|
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells |
6.77 |
|
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device |
6.75 |
|
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] |
6.73 |
|
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. |
6.72 |
|
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer |
6.72 |
|
Transcriptome of Stabilin-1 siRNA transfected human monocytes |
6.68 |
|
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. |
6.66 |
|
Induced DNA demethylation, genome instability and transcription |
6.63 |
|
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells |
6.63 |
|
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches |
6.53 |
|
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness |
6.5 |
|
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine |
6.37 |
|
HEK293 TFAM Knockout Expression Study |
6.23 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer |
6.22 |
|
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] |
6.22 |
|
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor |
6.15 |
|
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells |
6.07 |
|
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] |
6.06 |
|
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) |
6.04 |
|
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors |
6.04 |
|
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception |
6.02 |
|
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown |
6.0 |
|
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. |
5.85 |
|
Endothelial gene expression analysis |
5.85 |
|
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies |
5.84 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] |
5.8 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation |
5.8 |
|
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney |
5.78 |
|
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) |
5.74 |
|
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes |
5.68 |
|
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. |
5.68 |
|
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. |
5.64 |
|
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells |
5.54 |
|
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues |
5.47 |
|
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma |
5.42 |
|
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection |
5.35 |
|
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease |
5.34 |
|
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma |
5.3 |
|
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer |
5.25 |
|
CSL |
5.17 |
|
CSL RNA-Seq on HKC and SCC cell lines |
5.17 |
|
Primary Human B-cell Temporal Response to CD40L Stimulation |
5.11 |
|
The cytokine environment influence on human skin-derived T cells |
5.06 |
|
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness |
5.06 |
|
Dilated cardiomyopathy vs Myocarditis |
4.97 |
|
Differential responses of human fetal brain neural stem cells to Zika virus infection |
4.93 |
|
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown |
4.85 |
|
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells |
4.82 |
|
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis |
4.62 |
|
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation |
4.54 |
|
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 |
4.53 |
|
Iron response of HepG2 cells |
4.52 |
|
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] |
4.48 |
|
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System |
4.45 |
|
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence |
4.33 |
|
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG |
4.33 |
|
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] |
4.33 |
|
The DPYSL2 gene connects mTOR and schizophrenia |
4.23 |
|
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] |
4.15 |
|
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition |
4.15 |
|
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis |
4.01 |
|
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] |
3.92 |
|
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation |
3.92 |
|
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis |
3.91 |
|
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium |
3.86 |
|
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] |
3.83 |
|
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 |
3.83 |
|
The transcriptome and chromatin accessbility landscape of mammalian germline |
3.79 |
|
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma |
3.78 |
|
ARS2 is a general suppressor of pervasive transcription [RNAseq] |
3.76 |
|
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors |
3.72 |
|
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses |
3.62 |
|
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells |
3.6 |
|
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells |
3.59 |
|
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection |
3.56 |
|
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans |
3.55 |
|
4sUDRB-seq: measuring transcription elongation and initiation genomewide |
3.52 |
|
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs |
3.38 |
|
RNA editing in nascent RNA affects pre-mRNA splicing |
3.37 |
|
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
3.26 |
|
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. |
3.21 |
|
Human Treg NaCl stimulation |
3.2 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
3.13 |
|
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] |
3.07 |
|
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress |
3.07 |
|
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma |
2.99 |
|
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] |
2.91 |
|
SLAM-seq for K562 endogenous mRNA decay |
2.89 |
|
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors |
2.85 |
|
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities |
2.84 |
|
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy |
2.79 |
|
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells |
2.76 |
|
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid |
2.71 |
|
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] |
2.71 |
|
Exogenous rescue of KLHL9 in SF210 cell line |
2.59 |
|
Profiling of escape kinetics of viruses subjected to RNAi |
2.5 |
|
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells |
2.5 |
|
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication |
2.47 |
|
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) |
2.45 |
|
Cell cycle dynamics of human pluripotent stem cells primed for differentiation |
2.45 |
|
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process |
2.44 |
|
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment |
2.42 |
|
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients |
2.39 |
|
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene |
2.37 |
|
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells |
2.37 |
|
6mer seed toxicity in tumour suppressive microRNAs |
2.3 |
|
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures |
2.29 |
|
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells |
2.28 |
|
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines |
2.25 |
|
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 |
2.23 |
|
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii |
2.22 |
|
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) |
2.21 |
|
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells |
2.21 |
|
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex |
2.18 |
|
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome |
2.18 |
|
Measure transcript integrity using RNA-seq data |
2.14 |
|
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women |
2.08 |
|
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes |
2.03 |
|
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum |
1.94 |
|
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) |
1.89 |
|
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer |
1.86 |
|
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease |
1.85 |
|
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis |
1.83 |
|
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing |
1.72 |
|
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) |
1.72 |
|
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy |
1.64 |
|
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response |
1.64 |
|
Interaction between mitoNEET and NAF-1 in cancer cells |
1.6 |
|
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells |
1.58 |
|
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma |
1.57 |
|
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements |
1.56 |
|
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors |
1.48 |
|
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers |
1.48 |
|
Identification of long noncoding RNAs regulated by p53 |
1.46 |
|
Primate-specific gene TMEM14B promotes cortical expansion and folding |
1.45 |
|
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption |
1.45 |
|
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells |
1.39 |
|
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs |
1.38 |
|
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer |
1.32 |
|
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes |
1.26 |
|
ADAR1-editing of cellular and measles virus-derived duplex RNA |
1.26 |
|
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) |
1.2 |
|
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. |
1.15 |
|
Metastasis in triple-negative breast cancer |
1.15 |
|
Induction of Cardiomyocyte Proliferation [pz-822_human] |
1.1 |
|
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration |
1.1 |
|
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses |
1.09 |
|
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) |
0.99 |
|
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells |
0.99 |
|
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency |
0.99 |
|
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells |
0.99 |
|
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) |
0.97 |
|
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. |
0.92 |
|
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming |
0.9 |
|
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) |
0.88 |
|
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] |
0.88 |
|
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma |
0.84 |
|
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids |
0.83 |
|
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes |
0.8 |
|
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa |
0.75 |
|
Identification of a LIF-responsive replication-competent human β cell |
0.75 |
|
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma |
0.72 |
|
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. |
0.71 |
|
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) |
0.62 |
|
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
0.39 |
|
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line |
0.39 |
|
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 |
0.38 |
|
Methylation DNA mediated KLF4 binding activity in glioblastoma cells |
0.37 |
|
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. |
0.36 |
|
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation |
0.35 |
|
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] |
0.25 |
|
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles |
0.25 |
|
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles |
0.21 |
|
Enhancer activation during EGF response |
0.15 |
|
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale |
0.11 |
|
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome |
0.05 |
|
Transcriptomic analysis of human macrophages in 3D |
0.03 |
|
The role of m6A/m-RNA methylation in stress response regulation |
0.01 |
|
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients |
0.01 |